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Stenotrophomonas maltophilia
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Abstract
Background: Stenotrophomonas maltophilia is an emerging nosocomial pathogen that causes infection in
immunocompromised patients. S. maltophilia isolates are genetically diverse, contain diverse virulence factors, and
are variably pathogenic within several host species. Members of the Stenotrophomonas genus are part of the native
microbiome of C. elegans, being found in greater relative abundance within the worm than its environment,
suggesting that these bacteria accumulate within C. elegans. Thus, study of the C. elegans-Stenotrophomonas
interaction is of both medical and ecological significance. To identify host defense mechanisms, we analyzed the C.
elegans transcriptomic response to S. maltophilia strains of varying pathogenicity: K279a, an avirulent clinical isolate,
JCMS, a virulent strain isolated in association with soil nematodes near Manhattan, KS, and JV3, an even more
virulent environmental isolate.
Results: Overall, we found 145 genes that are commonly differentially expressed in response to pathogenic S.
maltophilia strains, 89% of which are upregulated, with many even further upregulated in response to JV3 as
compared to JCMS. There are many more JV3-specific differentially expressed genes (225, 11% upregulated) than
JCMS-specific differentially expressed genes (14, 86% upregulated), suggesting JV3 has unique pathogenic
mechanisms that could explain its increased virulence. We used connectivity within a gene network model to
choose pathogen-specific and strain-specific differentially expressed candidate genes for functional analysis.
Mutations in 13 of 22 candidate genes caused significant differences in C. elegans survival in response to at least
one S. maltophilia strain, although not always the strain that induced differential expression, suggesting a dynamic
response to varying levels of pathogenicity.
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Conclusions: Variation in observed pathogenicity and differences in host transcriptional responses to S. maltophilia
strains reveal that strain-specific mechanisms play important roles in S. maltophilia pathogenesis. Furthermore,
utilizing bacteria closely related to strains found in C. elegans natural environment provides a more realistic
interaction for understanding host-pathogen response.
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Background
Stenotrophomonas maltophilia is a Gram-negative, noso-
comial pathogen that can cause infection in immuno-
compromised patients. S. maltophilia is often found in
patients with cystic fibrosis and lung cancer, and is asso-
ciated with infections such as pneumonia, endocarditis,
bacteremia, and meningitis [1]. Although not highly
virulent, S. maltophilia is multi-drug resistant and cap-
able of forming biofilms [2, 3] thus developing treatment
methods for this pathogen is becoming an increasing
concern. S. maltophilia is ubiquitous within the environ-
ment, commonly found in aqueous sources, soils, and
associated with plant roots, and can also be isolated in
hospitals from water sources and medical devices [1, 4].
Sequencing and functional analyses have identified both
similarities and differences in virulence factors such as anti-
biotic resistance and quorum sensing mechanisms in clin-
ical and environmental isolates of S. maltophilia [5–10].
Therefore, strain diversity appears to result in different
virulence mechanisms and pathogenic potential [5, 11]. Al-
though studies have identified virulence factors within S.
maltophilia genomes, phenotypic analysis using host spe-
cies is rarely performed, and mechanisms of host responses
are poorly understood. Therefore, we recently established
Caenorhabditis elegans as a model to study host responses
to S. maltophilia infection [12].
C. elegans is an excellent genetic model organism for
studying many biological processes, including develop-
ment, neurobiology, and innate immunity. C. elegans are
bacterivores and can be found in the natural environ-
ment in decaying fruits and stems where they are in con-
tact with many bacterial species. Recent studies have
found that Stenotrophomonas is one of the most abun-
dant genera of bacteria found in the native microbiome
of C. elegans [13–15]. Furthermore, Stenotrophomonas is
found in higher abundance within the microbiome than
in rotting substrates where C. elegans are found [14, 15],
suggesting that it colonizes and accumulates in the intes-
tine, a common signature of pathogenesis in C. elegans
[16, 17]. In fact, many of these Stenotrophomonas iso-
lates were found to be detrimental to the health of C.
elegans, while few were found to be beneficial [14, 18].
This is consistent with previous observations that S.
maltophilia strains show varying pathogenicity to C.
elegans, amoeba (Dictyostelium discoideum and Acanth-
amoeba castellanii), and zebrafish [6, 8, 12]. This sug-
gests that S. maltophilia strains utilize different
virulence mechanisms that result in different host
responses.
Many innate immune pathways in C. elegans are con-
served from invertebrates to mammals, making it an ex-
cellent model for studying pathogen-host interactions
and innate immunity. Briefly, the p38 mitogen-activated
protein kinase (MAPK) pathway plays a role in defense
against several pathogens, including S. maltophilia,
Pseudomonas aeruginosa, Staphylococcus aureus, and
Salmonella enterica [12, 19–21]. In addition, activation
of the insulin-like signaling pathway decreases bacterial
packing, suggesting that regulation of genes by the
downstream transcription factor DAF-16 defends against
accumulation of bacteria in the intestine [16]. Analyses
of mutations affecting genes in these pathways have
identified downstream proteins involved in pathogen
defense, such as lysozymes, C-lectins, and CUB-domain
containing proteins [22, 23].
Although many important innate immune pathways
and effectors have been identified, there are differences
in responses to different bacterial pathogens. For ex-
ample, one study comparing responses to intestinal
pathogens Serratia marcescens, Enterococcus faecalis,
and Photorhabdus luminescens found that only 11% of
genes in C. elegans where commonly differentially
expressed in response to all three species [24]. This
phenomenon could be due to species-specific responses
to different pathogens, or the ability of bacteria to ma-
nipulate different host responses. Therefore, it is essen-
tial to study a variety of pathogens in order to fully
understand the complexity of genetic mechanisms
underlying pathogen defense. Finally, studying bacteria
that have been identified as part of the microbiome of C.
elegans, or their close relatives, more closely approxi-
mates natural interactions and therefore a more realistic
response to the bacteria.
We previously used a microarray approach to identify
gene expression patterns in response to Escherichia coli
OP50 and S. maltophilia strains K279a and JCMS [25].
We found that the genetic response is more specific to
the type of C. elegans-bacterial interaction rather than
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bacteria species or strain. Here, we further explore these
responses using RNA sequencing to identify and
characterize the genetic responses of C. elegans to sev-
eral different S. maltophilia strains of varying levels of
pathogenicity. Specifically, we performed transcriptomic
analysis on C. elegans following exposure to either E. coli
OP50 or one of three S. maltophilia strains: two patho-
genic environmental isolates, JCMS and JV3, and one
nonpathogenic clinical isolate, K279a. Using this experi-
mental set-up, we discovered responses that are com-
mon to both pathogenic S. maltophilia strains and
responses that are strain-specific based on the level of
virulence of each strain. We also identified candidate
genes involved in both the common and strain-specific
responses and determined that several candidate genes
were important for survival of C. elegans upon exposure
to S. maltophilia.
Results
We used survival as an indicator of bacterial pathogen-
icity to C. elegans. Survival analyses showed that S. mal-
tophilia strains K279a, JCMS, and JV3, display differing
levels of pathogenicity to C. elegans. S. maltophilia
K279a, a clinical isolate of S. maltophilia, is not patho-
genic, as worms fed K279a have similar bacterial load
and survival as do worms fed the standard lab food E.
coli OP50 [12] (Fig. 1). However, S. maltophilia JCMS, a
strain isolated in association with soil nematodes and S.
maltophilia JV3, another environmental isolate closely
related to JCMS, are both detrimental to the survival of
C. elegans (Fig. 1). We used the Cox proportional haz-
ards test to quantify these differences by calculating the
hazard, or the probability of a nematode dying at a given
time, for each bacterial treatment. Hazards ratios are
used to compare relative hazards of different conditions,
in this case bacteria, where ratios greater than one indi-
cate treatments that are more detrimental, or hazardous,
to the health of C. elegans; whereas hazard ratios less
than one indicate more beneficial conditions. C. elegans
exposed to JCMS have a hazard of 6.66 (±0.07), meaning
they are 6.66 times more likely to die than C. elegans ex-
posed to OP50, whereas C. elegans exposed to JV3 are
95.64 (±0.08) times more likely to die than C. elegans
fed OP50. We performed a transcriptomic analysis to
discover the genes underlying the response of C. elegans
to strains of S. maltophilia of varying pathogenicity to
provide a more comprehensive understanding of C. ele-
gans-pathogen interactions.
C. elegans exhibit common and strain-specific responses
to S. maltophilia
To investigate transcriptomic responses to S. maltophi-
lia, RNA-sequencing was performed after 12 h of expos-
ure to pathogenic S. maltophilia JCMS or JV3, or
nonpathogenic S. maltophilia K279a or E. coli OP50.
The 12-h time point was chosen based on previous ob-
servations that accumulation of bacteria occurs by this
time [12] but S. maltophilia JV3-induced mortality has
not yet begun (Fig. 1). In addition, other groups have
identified transcriptional changes at 4–8 h of exposure
to pathogens, including S. aureus, Bacillus thuringiensis,
and P. aeruginosa [23, 26, 27]. Therefore, at 12 h, patho-
gen recognition has begun, but transcriptional changes
associated with aging and mortality, which correlate with
a decreased immune response [28], should not compli-
cate interpretation of data.
Overall gene expression patterns were analyzed using
a heatmap of genes that were significantly differentially
expressed between any two treatments (Fig. 2; Supple-
mental Table 1, Additional File 1). Transcripts were con-
sidered differentially expressed if they had a false
discovery rate (FDR)-adjusted p-value of less than 0.05
and an absolute fold change greater than two. Gene ex-
pression profiles showed clustering of nonpathogenic
(K279a and E. coli OP50) and pathogenic (JCMS and
JV3) treatments (Fig. 2). Although there are differences
between expression profiles of the nonpathogenic
strains, suggesting the existence of a species-specific re-
sponse, the expression profiles of the nonpathogenic
treatments were more similar than that of the patho-
genic treatments (Fig. 2). Therefore, to identify the com-
mon response to pathogenic S. maltophilia, we
compared differentially expressed genes in C. elegans be-
tween pathogenic and nonpathogenic treatments (Fig. 3).
In total, 1296 genes were significantly differentially
expressed when comparing worms fed any pathogenic
(JV3 and JCMS) to any nonpathogenic (K279a and E.
Fig. 1 S. maltophilia strains show varying pathogenicity to C.
elegans. Survivorship of wild-type nematodes on S. maltophilia JCMS,
K279a, JV3, and E. coli OP50. Survival estimates were determined
using Kaplan-Meier estimates generated in R. This data contains all
wild-type data collected from experiments in this study, representing
23 individual experiments and n = 516–615 for each bacterial
treatment. Sample sizes, hazard ratios and p-values generated form
Cox proportional hazards tests are shown in Table 3
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coli OP50) strain, with 11% (145) commonly differen-
tially expressed between all pathogenic and nonpatho-
genic comparisons (Fig. 3, Supplemental Table 2;
Supplemental Table 3, Additional File 1) These most
likely represent a core set of genes that are regulated
upon exposure to pathogenic S. maltophilia and are
therefore referred to as the “common pathogenic S. mal-
tophilia response” (CPSR). Because these genes are dif-
ferentially expressed in response to pathogenic vs
nonpathogenic strains of the same species, this should
remove general responses to S. maltophilia and repre-
sent genes specifically involved in pathogen response to
S. maltophilia. Of the 145 CPSR genes, 129 (89%) were
upregulated in response to the pathogenic strains as
compared to the nonpathogenic strains, whereas 15
(10%) were downregulated (Supplemental Table 3, Add-
itional File 1). One gene, lys-10, is upregulated in re-
sponse to the pathogenic strains compared to OP50 but
downregulated in response to pathogenic strains com-
pared to K279a. Interestingly, most upregulated genes,
90 of 129, were even further upregulated in response to
JV3 as compared to JCMS. Because JV3 is more virulent
than JCMS, this suggests that the level of virulence influ-
ences the expression of S. maltophilia-induced genes.
A gene ontology (GO) enrichment analysis was per-
formed on all CPSR genes using the Database for Anno-
tation, Visualization and Integrated Discovery (DAVID)
Fig. 2 Heatmap of C. elegans differentially expressed genes in response to S. maltophilia. Differentially expressed genes from RNA-sequencing
include genes with fold-change > 2 and FDR-adjusted p-value < 0.05 between any treatment comparisons. Heatmap was generated with log
transformed FPKM values and visualized using the heatmap.2 function in gplots package in R. Dendrogram on the y-axis represents degree of
similarity of treatments based on gene expression profiles. Dendrogram on the x-axis represents degree of similarity of gene clusters based on
expression profile across treatments. Gene expression is color coded, with red indicating lower expression and yellow indicating higher
expression. The scaling option was used so that each gene is individually normalized across treatments
Fig. 3 C. elegans expresses a common set of 145 genes in response
to pathogenic S. maltophilia strains. Differential expression was
determined between each pathogenic and nonpathogenic
comparison, with the number of significantly differentially expressed
genes indicated between each set of comparisons. Genes included
are differentially expressed between the specified treatments with
fold-change > 2 and FDR-adjusted p-value < 0.05. 145 genes were
commonly differentially expressed between all pathogenic (JCMS
and JV3) and nonpathogenic (K279a and OP50) treatments, or the
common pathogenic S. maltophilia response (CPSR), indicated by
the asterisk
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[29, 30] to identify common cellular components, bio-
logical processes, and molecular functions of these
genes. The terms “biological process of innate immune
response” (FDR = 1.48E-51), “biological process of
defense to Gram-negative bacterium” (FDR = 4.19E-11),
“molecular function of carbohydrate binding” (FDR =
1.84E-4), and “cellular component of membrane raft”
(FDR = 8.13E-20) were all significantly enriched among
the CPSR genes (Table 1). We also analyzed GO enrich-
ment for the up- and down-regulated genes separately.
Enriched GO terms for the upregulated CPSR genes
were very similar to those for all CPSR genes (Supple-
mental Table 6, Additional File 2), whereas analysis of
downregulated genes resulted in no significant GO
terms with FDR < 0.05, possibly due to the small number
of downregulated CPSR genes (15).
To identify JV3- and JCMS-specific responses, we
identified genes that were differentially expressed in re-
sponse to JV3 and JCMS as compared to all other
strains. We found 31 genes differentially expressed in re-
sponse to JCMS vs the nonpathogenic strains and 327
genes differentially expressed in response to JV3 vs the
nonpathogenic strains (Fig. 3). We found that 14 of the
31 JCMS vs nonpathogenic strains genes were also dif-
ferentially expressed between JV3 and JCMS (Supple-
mental Table 4, Additional File 1). These genes are
specifically regulated upon exposure to S. maltophilia
JCMS and are therefore referred to as the “JCMS-spe-
cific response” (JSR). Of the 14 JSR genes, 12 are upreg-
ulated in response to JCMS as compared to all other
strains, whereas two are downregulated (Supplemental
Table 4, Additional File 1).
We found that 225 of the 327 JV3 vs nonpathogenic
strain genes were also differentially expressed between
JV3 and JCMS (Fig. 3; Supplemental Table 5, Additional
File 1). These genes are specifically regulated upon ex-
posure to S. maltophilia JV3 and are referred to as the
“JV3-specific response” (VSR). Although most CPSR
genes are upregulated in response to JV3, a majority
(89%) of the VSR genes are downregulated in response
to JV3 as compared to the other strains (Supplemental
Table 5, Additional File 1). This suggests that one viru-
lence mechanism employed by JV3 may be to reduce ex-
pression of a variety of host genes. GO enrichment
analyses of these genes reveals enrichment of several
metabolic processes and enzymes, including “biological
process of flavonoid glucuronidation” (FDR = 3.02E-09),
“biological process of oxidation-reduction process”
(FDR = 0.0433), “molecular function of glucuronosyl-
transferase activity” (FDR = 9.7E-06), and “molecular
function of carboxylic ester hydrolase activity” (FDR =
7.24E-04) (Table 2).
Again, we also analyzed GO enrichment for the up-
and down-regulated VSR genes separately. Downregu-
lated enriched GO terms were very similar to those for
all VSR genes (Supplemental Table 7, Additional File 2),
whereas analysis of upregulated genes resulted in no sig-
nificant GO terms with and FDR < 0.05, possibly due to
the small number of upregulated VSR genes.
Gene network analysis to prioritize important response
genes
We next wanted to determine whether the CPSR, JSR,
and VSR genes are important for the response to both
pathogenic S. maltophilia strains (CPSR genes) or to
specific strains of S. maltophilia (JSR and VSR genes).
To do this, we utilized WormNet, a probabilistic gene
network model, to prioritize genes for functional analysis
[31]. WormNet uses both direct physical and/or genetic
interactions as well as inferred interactions to create a
gene network that comprises 75.4% (15,139 genes) of the
C. elegans genome, resulting in 999,367 functional link-
ages [31]. Previously, gene networks have been used to
identify genes essential for C. elegans development and
Table 1 Innate immune response GO terms significantly enriched in common pathogenic S. maltophilia response (CPSR) genes
GO category Term Count % FDR
Biological process response to stimulus 60 43.48 4.19E-11
response to stress 55 39.86 3.47E-31
defense response 52 37.68 2.33E-46
innate immune response 50 36.23 1.48E-51
defense response to bacterium 16 11.59 6.58E-12
defense response to Gram-negative bacterium 14 10.14 4.19E-11
Molecular function carbohydrate binding 12 8.70 1.84E-04
Cellular component membrane raft 17 12.32 8.13E-20
Gene ontology (GO) enrichment analysis was performed on the CPSR genes using DAVID Bioinformatics Resources 6.8. Of the 145 CPSR genes, 138 were identified
in DAVID and considered for analysis. GO analysis identifies terms relating to the biological process, molecular function, or cellular component that are
significantly enriched among a list of genes. Indented terms indicate child terms, or subcategories, of the term listed above, with the parent term left-aligned.
Note that the degree of indention of each term does not reflect absolute GO term level within each category. Count is the number of genes corresponding to
each GO term. Percent is the count/138 total analyzed. FDR is the false discovery rate-corrected EASE enrichment score to account for multiple testing. Only terms
with FDR <0.05 and the most descriptive term for each unique gene list are shown
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survival under standard conditions, as well as identifica-
tion of genes associated with particular diseases [32, 33].
In addition, we previously found this method to be help-
ful to identify functionally important S. maltophilia-in-
duced genes [25]. Therefore, we hypothesize that the
most connected genes within the gene network play a
significant role in S. maltophilia response and are there-
fore better candidates for functional analyses. In addition
to gene network connectivity, we preferentially chose
genes for functional analysis with available alleles, either
from the Caenorhabditis Genetics Center (CGC) or pre-
viously generated in our lab, and generated mutant al-
leles using CRISPR/Cas9 for additional genes that were
expressed at higher levels.
Of the 145 CPSR genes, 73 were connected within the
gene network with an AUC of 0.6972 (p = 1.8E-16)
(Fig. 4; Supplemental Table 8, Additional File 3). The
AUC is the area under the receiver operating character-
istic (ROC) curve and provides a measure for the recov-
ery of true-positive genes as compared to false-positive
genes [31]. A random network would have an AUC of
0.5, whereas a network representing perfect prediction
of all connections would have an AUC of one; therefore,
an AUC of 0.6972 (p = 1.81E-16) suggests relatively high
predictive power of gene connections. Each connected
gene is ranked based on the number of connections
as well as the strength of the evidence for those con-
nections [32], with some of the highest-ranking CPSR
genes including lys-1, lys-2, dod-22, dod-19, and clec-
67 (Supplemental Table 8, Additional File 3). Previous
studies have identified these genes as downstream ef-
fectors of defense pathways or directly involved in re-
sponse to bacterial pathogen challenge [12, 22, 34,
35]. Mutant alleles were available for these genes,
along with alleles of several other genes highly con-
nected within the network, including F55G11.8,
ZK6.11, T24B8.5, and scl-2. In addition, we had previ-
ously generated mutant alleles affecting K08D8.4,
B0024.4, and F08G2.5 using CRISPR/Cas9
(Additional File 4).
Of the 225 VSR genes, 128 are connected within the
network (AUC = 0.6776, p = 2.81E-22) (Fig. 5; Supplemen-
tal Table 9, Additional File 3). Available alleles of several
of the highest-ranking genes in this network, including
sodh-1, dhs-3, F13D12.6, pho-1, acdh-1, C55A6.7, dhs-2,
and F08A8.4 were used for functional analysis.
Because of the small number of JSR genes, WormNet
was not used to prioritize these genes for functional ana-
lysis. Many of these genes had very low overall expres-
sion. Therefore, genes were chosen if the total fragments
per kilobase per million mapped reads (FPKM) for all
four treatments was greater than 30. We used an
available allele of the upregulated gene nhr-110 and
used CRISPR/Cas9 to generate a deletion of the
downregulated gene W02A2.8 for functional analysis
(Additional File 4).
Table 2 Metabolism and enzyme GO terms significantly enriched in S. maltophilia JV3-specific response (VSR) genes
GO category Term Count % FDR
Biological process single-organism metabolic process 49 22.68 2.47E-06
Small molecule metabolic process 27 12.5 5.27E-04
organic acid metabolic process 22 10.19 1.64E-05
carboxylic acid metabolic process 21 9.72 2.21E-05
monocarboxylic acid metabolic process 18 8.33 8.53E-07
flavonoid glucuronidation 14 6.48 3.02E-09
flavonoid biosynthetic process 14 6.48 3.02E-09
oxidation-reduction process 21 9.72 0.0433
transition metal ion transport 7 3.24 0.0468
Molecular function catalytic activity 89 41.20 0.00174
transferase activity, transferring glycosyl groups 17 7.87 0.00203
transferase activity, transferring hexosyl groups 14 6.48 1.76E-07
glucuronosyltransferase activity 12 5.56 9.70E-06
UDP-glycosyltransferase activity 16 7.41 0.00155
carboxylic ester hydrolase activity 11 5.09 7.24E-04
Cellular component extracellular region 20 9.26 0.0295
Gene ontology (GO) enrichment analysis was performed on the VSR genes using DAVID Bioinformatics Resources 6.8. Of the 225 VSR genes, 216 were identified in
DAVID and considered for analysis. GO analysis identifies terms relating to the biological process, molecular function, or cellular component that are significantly
enriched among a list of genes. Indented terms indicate child terms, or subcategories, of the term listed above, with the parent term left-aligned. Note that the
degree of indention of each term does not reflect absolute GO term level within each category. Count is the number of genes corresponding to each GO term.
Percent is the count/216 total analyzed. FDR is the false discovery rate-corrected EASE enrichment score to account for multiple testing. Only terms with FDR <
0.05 and the most descriptive term for each unique gene list are shown
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Functional analysis of common S. maltophilia and strain-
specific genes
Survivorship of mutants compared to wild-type C. ele-
gans, quantified by Cox proportional hazards test, was
used to determine whether candidate genes were im-
portant for response to treatment bacteria E. coli OP50
and S. maltophilia K279a, JCMS, and JV3. We tested the
simple hypothesis that CPSR genes are important for re-
sponse to both JCMS and JV3, JSR genes are important
for response to JCMS, and VSR genes are important for
response to JV3; therefore, mutants of these genes will
result in increased or decreased susceptibility to JCMS
and JV3, just JCMS, or just JV3, respectively, as com-
pared to wild-type.
Mutations in four of the 12 CPSR candidate genes
(lys-1, K08D8.4, ZK6.11, and dod-19) caused significantly
increased susceptibly to JCMS, while three mutations
(B0024.4, K08D8.4, and T24B8.5) also caused increased
susceptibility to JV3 (Fig. 6; Table 3; Additional File 5).
Mutations in two of these genes (K08D8.4 and lys-1)
also increased susceptibility to K279a (Fig. 6; Table 3;
Additional File 5). All of these genes, apart from
B0024.4, were previously reported to play a role in in-
nate immune response based on GO terms. In addition,
mutations in lys-1 caused increased susceptibility to E.
coli OP50, while scl-2 caused decreased susceptibility to
OP50. Overall, mutations in seven of the 12 CPSR genes
caused significant differences in survival in response to
at least one bacterial treatment.
Mutations in three of the eight VSR candidate genes
(acox-1.4, dhs-3, dhs-2) caused significantly decreased
survival in response to JV3, while mutations in acdh-1
resulted in increased lifespan (Fig. 6; Table 3; Add-
itional File 6). However, worms with mutations in all
four of these genes also result in significant differences
in survival in response to at least one other bacterial
strain tested, suggesting that although these genes are
specifically differentially expressed in response to JV3,
they are also important for survival under other condi-
tions. Additionally, mutations in C55A6.7 and pho-1 de-
creased susceptibility to K279a, and mutations in pho-1
and sodh-1 increased susceptibility to JCMS (Fig. 6;
Table 3; Additional File 6). Overall, seven of the eight
VSR genes are important for the response to at least one
S. maltophilia strain. Interestingly, while only two of the
eight genes are involved in innate immune response
based on GO terms (C55A6.7 and acdh-1), seven of the
eight genes have GO terms associated with metabolic
Fig. 4 Gene network analysis was used to prioritize CPSR genes. WormNet v2, a probabilistic functional gene network model, was queried with
the 145 genes that were differentially expressed in response to non-pathogenic vs. pathogenic strains. 73 of the 145 genes are connected to one
another (AUC = 0.6942, p = 1.8137e-16). a Network visualized using Cytoscape 3.5.1. Green circles represent individual genes and grey lines
represent known or predicted connections between genes. Genes are numbered and sized based on rank (Supplemental Table 8, Additional File
3); darker green circles indicate genes that were chosen for functional analysis. b Top 20 ranked genes. Rank is determined based on score, which
is calculated based on number of connections and the strength of evidence for those connections. Regulation indicates direction of differential
expression in response to pathogenic compared to nonpathogenic strains
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processes, including oxidation-reduction (acdh-1, acox-
1.4, dhs-3, dhs-2, sodh-1), proteolysis (F13D12.6), and
dephosphorylation (pho-1). In addition, all of these
genes, except dhs-2 and C55A6.7, have been shown to
be expressed in the intestine [36–39] (Fig. 7), the site of
S. maltophilia accumulation and proposed pathogenesis
[12]. Therefore, although these genes do not seem to be
important exclusively for JV3 survival, they do seem to
be important for survival in response to S. maltophilia
overall. Mutations in acdh-1 and acox-1.4 also increased
susceptibility to E. coli OP50, possibly suggesting a more
general role in C. elegans survival.
Only two JSR genes were functionally analyzed, nhr-
110 and W02A2.8. nhr-110 mutants were significantly
less susceptible to OP50, but no differences were seen in
survival in response to JCMS or other S. maltophilia
strains (Fig. 6; Table 3; Additional File 7).
In addition to survival analyses, we visualized the ex-
pression patterns for several CPSR and VSR genes. Sev-
eral transgenic strains were available from stock centers,
including transcriptional reporters for T24B8.5, acdh-1,
sodh-1, and a translational reporter for dhs-3. We also
generated translational reporters for K08D8.4 and
F19B2.5. Intensity and location of expression were mea-
sured in response to all S. maltophilia strains and E. coli
OP50 at 12 and 24 h of exposure. Interestingly, at 12 h,
except for T24B8.5, expression patterns did not reflect
the RNA-sequencing results (Additional File 8). How-
ever, at 24 h, expression profiles of all expression con-
structs across treatments correlated with the RNA-
sequencing results (Fig. 7; Additional File 8). This delay
in observed differential expression of reporter constructs
could be due to multiple factors, including folding and
processing of fluorescent proteins, potential degradation
in down regulated tissues or accumulation of visible
amounts of fusion proteins. However, overall, these ob-
served patterns validate our transcriptomic results.
All of these genes were expressed in the intestine, but
localization of expression was also seen in the hypoder-
mis (sodh-1 and acdh-1), muscle (sodh-1), nervous sys-
tem (sodh-1), and head (K08D8.4, sodh-1, and acdh-1)
(Additional File 9). The intestine and hypodermis are
Fig. 5 Gene network analysis was used to prioritize VSR genes. WormNet v2, a probabilistic functional gene network model was queried with the
225 JV3-specific response (VSR) genes. 128 of the 225 genes are connected to one another (AUC = 0.6776, p = 2.81E-22). a Network was visualized
using Cytoscape 3.5.1. Blue circles represent individual genes and grey lines represent known or predicted connections between genes. Genes
are numbered and sized based on rank (Supplemental Table 9, Additional File 3); darker blue circles indicate genes that were chosen for
functional analysis. b Top 22 ranked genes. Rank is determined based on score, which is calculated based on number of connections and the
strength of evidence for those connections. Regulation indicates direction of differential expression in response to JV3 compared to all
other strains
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common sites of pathogen infection, whereas the ner-
vous system has also been shown to play a role in patho-
gen recognition and immune response in C. elegans
[40–43]. Therefore, expression of differentially expressed
genes in response to S. maltophilia correlates with com-
mon tissues involved in innate immune response.
Discussion
Patterns of gene expression in response to different
levels of S. maltophilia virulence
This study utilized a transcriptomic approach to identify
genetic responses to S. maltophilia strains of differing
pathogenicity. Our previous study that identified differ-
entially expressed genes in response to E. coli OP50, S.
maltophilia K279a, and S. maltophilia JCMS after 24 h
found almost all genes were differentially expressed
between nonpathogenic K279a and pathogenic JCMS,
suggesting that the nematode response differs only to
the presence of virulence. This study further examines
these findings by adding an even more pathogenic
strain, S. maltophilia JV3, to determine whether there
are strain similarities and differences based on level
of virulence. In this case, we identified differences in
the nematode response between species (E. coli and S.
maltophilia) and levels of virulence (Figs. 2, and 3).
However, the expression patterns between the non-
pathogenic strains are more similar than those of the
pathogenic strains (Fig. 2), suggesting that although
there are differences between species, the majority of
gene expression changes are based on the presence of
virulence.
To determine the existence of a common pathogenic
S. maltophilia response (CPSR), we identified 145 genes
that were differentially expressed between all pathogenic
and non-pathogenic comparisons (Fig. 3; Supplemental
Table 3, Additional File 1). A majority of these genes
(89%) were upregulated in response to JCMS and JV3
(Supplemental Table 3, Additional File 1). This is con-
sistent with previous transcriptomic patterns of genes
differentially expressed in C. elegans upon pathogen ex-
posure, in which a majority of genes were upregulated in
response to a variety of bacterial and fungal pathogens
[23, 24, 44]. However, another study that compared
transcriptomic responses to a variety of bacterial patho-
gens found that a majority of genes were down-
regulated in response to Gram-negative bacteria and up-
regulated in response to Gram-positive bacteria [45].
Furthermore, our previous study of the response of C.
elegans to S. maltophilia JCMS found a majority of
genes were down-regulated [25]. However, that study
used microarrays to detect expression differences in-
duced at 24 h of exposure, whereas here we used RNA
sequencing at 12 h of exposure. Therefore, this direc-
tionality of gene expression could be strain- or time-
specific. In fact, 200 of the 225 (89%) of the genes specif-
ically differentially expressed in response to JV3 (VSR
genes) are downregulated (Supplemental Table 5, Add-
itional File 1). This supports the idea that directionality
of gene expression in C. elegans may be strain specific,
and different virulence mechanisms or host responses
may play a role in these patterns.
Fig. 6 Relative survival of C. elegans mutants in CPSR, VSR, and JSR
genes. Relative survival, determined by Cox proportional hazards
mixed effects model, of mutants relative to wild-type on each
bacterial treatment. General linear hypothesis testing was used to
compare each mutant to wild-type on each bacterial treatment.
Heatmap was made in R with ggplot2 using the -β from the Cox
mixed effects model. The Benjamini-Hochberg procedure was used
to adjust p-values for false discovery rates associated with multiple
comparisons, with bold numbers and asterisks indicating significant
-β values (p-value < 0.05). Genes are ordered based on number of
bacteria in which phenotypic effects are observed
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Table 3 Cox proportional hazard ratios for common S. maltophilia and strain-specific genes
Relative to wildtype
Nematode Bacteria N M SE Hazard Ratio
exp(β)
p value
wildtype OP50 516 10.59 0.23 NA
K279a 615 10.87 0.19 NA
JCMS 608 5.44 0.07 NA
JV3 580 2.53 0.03 NA
CPSR genes B0024.4 OP50 26 10.50 0.78 0.88 0.698
(mh82) K279a 58 8.66 0.55 1.32 0.146
JCMS 90 4.74 0.16 1.28 0.14
JV3 58 2.06 0.07 1.54 .03*
F08G2.5 OP50 46 10.43 0.77 0.99 0.988
(mh86) K279a 59 10.85 0.68 1.03 0.897
JCMS 57 5.39 0.23 1.10 0.696
JV3 59 2.72 0.07 0.91 0.68
ZK6.11 OP50 46 12.24 0.74 0.76 0.194
(ok3738) K279a 57 10.39 0.62 1.12 0.636
JCMS 58 4.47 0.14 2.19 1.33E-6*
JV3 56 2.27 0.08 1.41 0.07
T24B8.5 OP50 58 10.69 0.60 1.04 0.897
(ok3236) K279a 61 10.20 0.60 0.97 0.923
JCMS 60 4.88 0.16 1.41 0.053
JV3 57 1.94 0.07 2.23 8.9E-7*
dod-19 OP50 56 11.84 0.64 0.76 0.14
(ok2679) K279a 60 9.80 0.57 1.13 0.577
JCMS 60 4.07 0.12 0.36 7.27E-11*
JV3 58 2.36 0.10 1.04 0.873
dod-22 OP50 74 10.22 0.54 1.23 0.216
(ok1918) K279a 90 13.23 0.41 0.83 0.216
JCMS 89 5.87 0.18 1.07 0.702
JV3 89 0.28 0.08 0.82 0.194
K08D8.4 OP50 79 10.95 0.66 0.92 0.696
(mh101) K279a 90 7.62 0.50 2.11 1.46E-8*
JCMS 87 4.82 0.17 1.68 .000154*
JV3 85 2.36 0.08 1.37 .038*
lys-1 OP50 82 10.09 0.42 1.46 .010*
(ok2445) K279a 90 9.17 0.44 1.67 .000147*
JCMS 88 4.76 0.14 1.92 1.33E-6*
JV3 86 2.77 0.08 0.78 0.129
clec-67 OP50 79 11.56 0.53 0.92 0.681
(ok2770) K279a 55 13.20 0.68 0.71 0.077
JCMS 57 5.46 0.24 1.06 0.8
JV3 53 2.67 0.10 1.00 0.988
lys-2 OP50 85 10.44 0.50 1.04 0.853
(tm2398) K279a 58 10.21 0.54 1.36 0.077
JCMS 58 5.71 0.19 0.92 0.698
JV3 55 2.59 0.08 1.13 0.606
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Table 3 Cox proportional hazard ratios for common S. maltophilia and strain-specific genes (Continued)
Relative to wildtype
Nematode Bacteria N M SE Hazard Ratio
exp(β)
p value
F55G11.8 OP50 59 10.51 0.61 0.89 0.601
(gk3130) K279a 58 11.55 0.51 0.79 0.216
JCMS 60 5.65 0.19 0.80 0.217
JV3 57 2.44 0.10 0.92 0.698
scl-2 OP50 51 15.43 0.73 0.49 2.97E-5*
(tm2428) K279a 54 11.72 0.64 0.85 0.45
JCMS 56 5.75 0.17 1.00 0.988
JV3 55 2.42 0.12 1.24 0.268
VSR genes acdh-1 OP50 50 7.12 0.77 1.68 .00688*
(ok1489) K279a 59 8.53 0.49 1.74 .00178*
JCMS 58 4.59 0.19 1.68 .00427*
JV3 58 2.68 0.11 0.62 .008*
sodh-1 OP50 53 10.55 0.64 1.09 0.698
(ok2799) K279a 54 9.48 0.56 1.41 0.065
JCMS 56 4.71 0.15 1.7 .00164*
JV3 55 2.5 0.11 0.97 0.897
pho-1 OP50 54 12.11 0.69 0.78 0.211
(tm5302) K279a 55 12.47 0.74 0.68 .0405*
JCMS 55 4.58 0.18 2.22 1.33E-6*
JV3 60 2.33 0.11 1.36 0.088
C55A6.7 OP50 57 11.91 0.69 0.80 0.234
(tm6807) K279a 59 13.51 0.75 0.52 4.71E-5*
JCMS 59 5.39 0.15 1.13 0.6
JV3 57 2.4 0.07 1.37 0.077
acox-1.4 OP50 58 9.91 0.42 1.53 .0137*
(tm6415) K279a 60 6.2 0.33 4.10 <2E-16*
JCMS 57 4.63 0.17 2.02 1.47E-5*
JV3 55 2.03 0.08 2.53 1.38E-8*
dhs-3 OP50 55 12 0.67 1.20 0.37
(tm6151) K279a 58 9.16 0.65 1.95 4.45E-5*
JCMS 55 4.87 0.15 2.41 4.04E-8*
JV3 55 2.04 0.08 2.97 2.31E-9*
F13D12.6 OP50 53 11.92 0.64 0.75 0.146
(tm7051) K279a 58 10.98 0.51 1.01 0.216
JCMS 56 6 0.15 0.82 0.32
JV3 57 2.59 0.12 0.88 0.566
dhs-2 OP50 27 9.3 0.80 1.24 0.474
(tm7516) K279a 53 7.72 0.43 1.78 .00095*
JCMS 53 4.91 0.20 1.11 0.681
JV3 53 1.64 0.09 2.74 2.35E-11*
JSR genes nhr-110 OP50 30 14.23 0.77 0.52 .00427*
(gk987) K279a 58 9.69 0.57 0.95 0.853
JCMS 58 5.16 0.13 1.06 0.8
JV3 57 2.29 0.07 1.13 0.619
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In comparison to VSR genes (225), there are very few
genes (14) specifically differentially expressed in re-
sponse to JCMS (JSR) (Supplemental Table 4, Additional
File 1) and most of these genes were expressed at low
levels. Overall, this suggests that at 12 h of exposure
JCMS does not employ unique virulence mechanisms as
it appears JV3 does and therefore does not lead to
unique host responses.
The CPSR and VSR genes identify functions that play
different roles in the response to S. maltophilia
We used GO enrichment and functional analysis of mu-
tations to begin to understand functional roles of the
CPSR genes. GO enrichment analysis identified pro-
cesses involved in defense response, particularly re-
sponse to Gram-negative bacteria, as well as a molecular
function in carbohydrate binding and the cellular com-
ponent of membrane raft (Table 1). Genes with the GO
term “molecular function of carbohydrate binding” all
belong to clec or lec family, which are structurally similar
to carbohydrate binding proteins. Although not all
nematode clec and lec genes encode molecules that bind
carbohydrates, many are predicted to be secreted pro-
teins that may act as immune effectors [34, 46]. Many
clec genes are expressed in the C. elegans intestine and
are differentially expressed in response to pathogens; a
recent review determined that 237 of 283 clec genes are
differentially expressed during pathogen infection [46].
We analyzed a mutation in only one clec gene, clec-67,
and no differences were found in survival between the
clec-67 mutant and wild-type. This might be explained
by functional redundancy among the clec family pro-
teins, as many of these proteins are structurally similar.
In fact, there are nine other clec genes among the CPSR
genes, three of which (clec-70, clec-83, and clec-85) are
paralogous to clec-67, suggesting similar functional roles.
Therefore, even though these genes may play a role in
innate immune response, mutations in one clec gene
alone may not result in an effect on survival upon
pathogen-challenge. Future work to interfere with the
functions of multiple clec genes at one time will shed
light on this possibility.
Membrane rafts, or lipid rafts, are membrane domains
that contain high concentrations of cholesterol and gly-
cosphingolipids [47]. Membrane rafts also serve as sites
of colocalization between membrane proteins and sig-
naling pathway components, such as components of
MAPK and insulin-like signaling pathways, both of
which are known to play roles in innate immunity and
defense in C. elegans [19–21, 47, 48]. In addition, many
of the CPSR membrane raft genes also have biological
processes associated with the innate immune response.
To further support this, mutations in three paralogous
membrane raft genes, B0024.4, ZK6.11, and dod-19,
caused increased susceptibility to either JCMS or JV3.
Mutations in two other genes, T24B8.5 and lys-1, were
also shown to increase susceptibility to at least one S.
maltophilia strain. T24B8.5 is regulated by the PMK-1
pathway [49], and lys-1 is regulated by the DBL-1 path-
way [22], both well-known innate immune pathways.
Therefore, it is possible that these membrane raft pro-
teins are involved in innate immune signaling pathways,
where increasing expression of the membrane raft pro-
teins results in increased signaling and therefore in-
creased expression of innate immune effector genes.
Further analysis of these membrane raft genes and their
potential role in innate immune signaling pathways
could reveal novel gene functions that are important
components in the response to S. maltophilia and po-
tentially other pathogens.
On the other hand, GO enrichment analysis of VSR
genes identified many processes and functions in-
volved in metabolism (Table 2). Genes with GO
terms “flavonoid glucuronidation”, “flavonoid biosyn-
thetic process”, and “UPD-glycosyltransferase” consist
almost entirely of glycosyltransferase family proteins,
a large protein family in C. elegans, comprising 265
genes [50]. However, a direct linkage between
Table 3 Cox proportional hazard ratios for common S. maltophilia and strain-specific genes (Continued)
Relative to wildtype
Nematode Bacteria N M SE Hazard Ratio
exp(β)
p value
W02A2.8 OP50 59 11.27 0.56 0.98 0.929
(mh87) K279a 59 10.42 0.65 1.00 0.988
JCMS 59 5.22 0.17 1.29 0.15
JV3 57 2.35 0.1 1.31 0.14
Mean survival (M), standard error of the mean (SE), and sample size (N), are given for each nematode genotype and bacterial treatment combination.
Wild-type statistics were determined from combining all wild-type data from all experiments. Hazard ratios (natural log(β)) indicate the treatment hazard
divided by the hazard of wild-type (first column) across all experiments. The hazard is defined as the probability of a nematode dying at a given time.
Hazard ratios and associated FDR adjusted p-values for each comparison were determined using Cox proportional hazards mixed effects model and
general linear hypothesis tests and applying the Benjamini-Hochberg procedure to adjust for multiple comparisons in R. Asterisk indicate significant p-
values (p<0.05)
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glycosyltransferases and innate immunity has not yet
been observed. Genes with GO term “oxidation-re-
duction process” include many dehydrogenase and
oxidase enzymes. Interestingly, mitochondria, the lo-
cation of many dehydrogenases, have been shown to
be involved in pathogen recognition [51]. Specifically,
FADH2-dependent dehydrogenase activity in mice
macrophages increases upon exposure to E. coli [52].
Furthermore, GO terms associated with metabolic
processes have previously been found to be enriched
among down-regulated genes in response to S. malto-
philia and B. thuringiensis [25, 27]. One explanation
might be that some pathogens, including S. maltophi-
lia JV3, utilize mechanisms to interfere with metabol-
ism in C. elegans, resulting in their own increased
virulence. On the other hand, this downregulation
may be a defense mechanism used by C. elegans to
decrease metabolites needed for pathogen survival or
pathogenesis. Five genes in this category, dhs-2, dhs-3,
acdh-1, sodh-1, and acox-1.4, were chosen for func-
tional analysis, and mutations in all had an effect on
survival in response to at least one S. maltophilia
strain. The involvement of VSR genes in general me-
tabolism could explain their more general effect on
survival (Fig. 6). However, further analyses of these
genes in C. elegans are needed to fully understand
their role in response to S. maltophilia JV3 and other
pathogens. These analyses, along with JV3 genome se-
quence analysis, could provide insight into unique
virulence mechanisms employed by JV3.
Fig. 7 A majority of tested CPSR and VSR genes are expressed in innate immune response tissues. Expression of several CPSR (T24B8.5, F19B2.5,
K08D8.4) and VSR (sodh-1, acdh-1, dhs-3) genes using transcriptional or translational fluorescent protein fusions upon exposure to S. maltophilia or
E. coli OP50. Up- or down- arrows below each gene name indicate direction of expression in reference to the pathogenic strains (up/down-
regulated in response to JV3 and/or JCMS). All transgenes are primarily expressed in the intestine, except for sodh-1, which is also expressed in
several other tissues. Columns show expression of worms exposed to E. coli OP50 and S. maltophilia K279a, JCMS, or JV3 for 24 h at 100x
magnification. The images chosen represent mean average intensity across 10–18 worms (see Additional File 8). Scale bar indicates 100 μm,
anterior is to the left, and ventral is up for all pictures. Note that expression in the AIY interneuron in the T24B8.5 transgenic strain is due to a ttx-
3:GFP marker and not T24B8.5 expression and the sodh-1 expression construct contains a nuclear localization signal
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In addition to strain-specific gene expression patterns,
we also observe strain-specificity in our functional ana-
lyses (Fig. 6). For example, while mutations in the VSR
gene acdh-1 increase susceptibility to OP50, K279a, and
JCMS, the same mutation causes a significant decrease
in susceptibility to JV3. A similar pattern is observed
with mutations in the CPSR gene lys-1 that also cause
increased susceptibility to OP50, K279a, and JCMS, but
non-significantly decreased susceptibility to JV3. This
further supports our hypothesis that JV3 utilizes unique
mechanisms that result in strain-specific genetic re-
sponses in C. elegans. Therefore, further understanding
the function of lys-1 and acdh-1 and their role in re-
sponse to JV3 may uncover information about its viru-
lence mechanisms.
Host responses could exist along a continuum of
response to increased pathogenicity
Overall, data from the survival analyses do not support
the simple hypothesis that CPSR genes are necessary for
survival on JCMS and JV3, while JSR and VSR genes are
necessary for survival on only JCMS or JV3, respectively,
as mutations in a majority of genes did not affect sur-
vival of C. elegans in that strain-specific manner (Fig. 6;
Table 3). However, it appears that overall, these genes
do play a role in response to S. maltophilia, as 13 of 22
candidate CPSR, JSR, and VSR gene mutants display sig-
nificant differences in survival upon exposure to at least
one S. maltophilia strain. Furthermore, mutations in
many of the genes we analyzed caused significant differ-
ences in survival upon exposure to K279a in addition to
the pathogenic strains, JCMS and JV3 (Fig. 6; Table 3).
Genome sequencing of S. maltophilia K279a has identi-
fied a variety of virulence factors [53], suggesting that it
may in fact have pathogenic potential. Whereas wild-
type C. elegans may be able to defend against K279a in-
fection, mutations in innate immune and defense genes
may cause C. elegans to become more susceptible to
K279a. Therefore, identifying and functionally analyzing
differentially expressed genes in C. elegans in response
to all S. maltophilia strains could also uncover import-
ant genetic components of the response to S. maltophi-
lia virulence.
Although RNA sequencing examines gene expres-
sion on a genome-wide scale, it only captures expres-
sion profiles at one point in time. Therefore, it is
possible that the interaction between C. elegans and
the different S. maltophilia strains is more nuanced
than predicted by the simple hypothesis that genes
differentially expressed at one point in time will affect
nematode survival. For example, because JV3 is more
virulent than JCMS and K279a, the JV3-exposed
worms could be at a more advanced stage of patho-
genesis than the JCMS and K279a-exposed worms at
12 h. Thus, in addition to any strain specific effects,
differential responses at a single time point might also
reflect different stages of pathogenesis. This idea is
supported by our observation that among the upregu-
lated CPSR genes, most were further upregulated in
response to JV3 as compared to JCMS (Supplemental
Table 3, Additional File 1). Survival analysis, unlike
RNA-sequencing, can provide information about gene
function across life history. The observation that mu-
tations in many genes differentially expressed in re-
sponse to specific S. maltophilia strains affect survival
upon exposure to multiple strains of S. maltophilia
suggests that these genes may be important for re-
sponse to S. maltophilia more generally. That these
mutations can cause varying effects on survival in re-
sponse to different strains also indicates complexities
of gene function within this general response. Tran-
scriptional analysis of the C. elegans response to dif-
ferent strains across time of exposure could help
determine the relative importance of time-specific and
strain-specific responses.
Conclusion
Using transcriptomic data to understand and analyze
responses to pathogens can provide insight into over-
all response patterns and pathogen virulence mecha-
nisms. Utilizing both transcriptional and functional
analyses, this study illustrates the previously sup-
ported idea that there are common signatures of
pathogen infection in C. elegans, but also unique spe-
cies and even strain specific responses. More specific-
ally, we provide evidence to support that different strains
of S. maltophilia of varying pathogenicity cause different
transcriptomic signatures, and JV3 elicits a unique down-
regulation of metabolic genes in C. elegans that are in-
volved in survival more generally. Therefore, to fully
understand virulence of bacteria and pathogenesis in C.
elegans for both clinical and environmental applications, a
variety of bacterial species and strains need to be investi-
gated. Because S. maltophilia is a human opportunistic
pathogen, understanding virulence mechanisms of and
host responses to a variety of S. maltophilia strains could
lead to novel information about S. maltophilia infection.
Finally, focusing on more natural host-pathogen interac-
tions promises to provide a more realistic understanding
of host responses.
Methods
Nematode and bacteria strains and growth
The following C. elegans strains were obtained from the
CGC: RB1573 dod-22(ok1918), VC1749
F55G11.8(gk3130) ZK185.2(gk828), VC3059
ZK6.11(ok3738), VC2477 T24B8.5(ok3236), RB1893 lys-
1(ok2445), VC2249 dod-19(ok2679), RB2095 clec-
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67(ok2770), VC2176 nhr-110 (gk987), RB2114 sodh-1
(ok2799), VC1011 acdh-1(ok1489), LIU1 [dhs-3p::dhs-3::
GFP + unc-76(+)], AU78 [T24B8.5p::GFP::unc-54-3′
UTR + ttx-3p::GFP::unc-54-3′ UTR], CF2124 [sodh-1p::
RFP (NLS) + rol-6(su1006)], VL717 [acdh-1p::GFP]. C.
elegans strains containing the following alleles were ob-
tained from the National BioResource Project (NBRP):
lys-2(tm2398), scl-2(tm2428), dhs-3(tm6151),
F13D12.6(tm7051), pho-1(tm5302), C55A6.7(tm6807),
dhs-2(tm7516), acox-1.4(tm6415). All alleles were out-
crossed 4 times and were screened by PCR after each
outcross to obtain homozygous mutants. Forward and
reverse primers used to test for each allele can be found
on Wormbase. Each of the mutations used in this study
have molecular lesions that indicate loss of gene func-
tion. Specific details of each mutation and its molecular
lesion can be found on Wormbase. Bristol N2 strain was
also obtained from the CGC and used as wild-type. All
strains were maintained on nematode growth media
(NGM) plates seeded with E. coli OP50 at 20 °C.
C. elegans strains containing the following expression
constructs and alleles were generated as described
below: mhEx284[F19B2.5p::F19B2.5::wrmScarlet::unc-54-
3′ UTR] and mhEx283[K08D8.4p::K08D8.4::wrmScarlet::
unc-54-3′ UTR], F08G2.5(mh86), K08D8.4(mh76),
B0024.4(mh82),W02A2.8(mh87).
Bacterial strains include E. coli OP50 from the CGC,
Stenotrophomonas maltophilia JCMS isolated by our lab
in association with nematodes from Konza Prairie near
Manhattan, KS [12], Stenotrophomonas maltophilia
K279a from R. Ryan (University College Cork), Stenotro-
phomonas maltophilia JV3 from J. Tiedje (Michigan
State University).
All bacteria strains were frozen at − 80 °C upon arrival
and thawed frequently for experimentation. S. maltophi-
lia strains are naturally Ampicillin resistant, thus were
grown on Luria Broth (LB) agar containing 100 μg/mL
Ampicillin to selectively isolate and maintain each strain
while avoiding contamination. E. coli OP50 was grown
on regular LB agar. Plates were incubated at 37 °C over-
night and kept at 4 °C thereafter. S. maltophilia strains
were grown in liquid LB containing 100 μg/mL Ampicil-
lin, and E. coli OP50 was grown in liquid LB and shaken
overnight at 37 °C. Liquid cultures were then seeded
onto NGM and grown at room temperature overnight
before being used for experimentation.
RNA isolation
Wild-type nematodes were synchronized by bleaching,
plated on E. coli OP50, and maintained at 20 °C. Syn-
chronized larval stage 4 (L4) worms were washed several
times in M9 buffer and transferred to treatment bacteria
or E. coli OP50. Treatments included S. maltophilia
strains K279a, JCMS, and JV3. After 12 h of exposure to
treatment bacteria at 25 °C, worms were collected in M9
buffer and lysed in TRIzol® (Life Technologies). 12 h of
exposure to treatments was chosen because at this point
bacterial accumulation in the intestine has begun [12],
but almost all worms in each treatment were still alive.
Only non-contaminated, un-starved populations were
used for RNA extraction, and three biological replicates
were collected for each treatment. Bulk RNA was ex-
tracted from these populations using PureLink RNA
Mini Kit (Invitrogen), and DNase treated using On-
Column PureLink® DNase Treatment (Invitrogen) fol-
lowing the manufacturer’s protocol. RNA quality was
checked by determining 260/280 and 260/230 absorb-
ance ratios using a NanoDrop™ 8000 Spectrophotometer
and observation of 18S and 28S rRNA bands using gel
electrophoresis.
RNA sequencing and analysis
Extracted RNA was sent to the University of Kansas
Center for Molecular Analysis of Disease Pathways
Genome Sequencing core facility for library prepar-
ation and sequencing. Three biological replicates, con-
sisting of pooled bulk nematode RNA, and two
technical replicates of each biological replicate were
sequenced for each treatment. Libraries were se-
quenced on Illumina HiSeq 2500 platform resulting in
100 base pair single-end reads. Sequence quality was
assessed using FastQC.
Tophat 2, which uses the short-read mapping pro-
gram Bowtie [54], was used to map reads to the C.
elegans genome. Technical replicates were combined
at this step. Transcriptome and genome versions
WS235 were used as the reference. Minimum intron
length was set to 15 base pairs (−i 15) and the par-
ameter for -no-novel-juncs was used. The remainder
of settings were set to default. Cuffdiff, a program
within Cufflinks, is used to compare expression of
transcripts at the isoform-level between treatments,
accounting for variability within biological replicates
[55]. The parameter -multi-read-correct was used to
account for reads mapping to multiple locations, with
the remainder of settings set to default. Transcripts
were considered significantly differentially expressed
between treatments if the fold change > 2 and the
false discovery rate (FDR)-adjusted p-value < 0.05.
Heatmap analysis and comparison of differentially
expressed genes between different conditions were
performed in R (Vienna, Austria: R Foundation for
Statistical Computing) using the heatmap.2 function
in the package gplots. Fragments per kilobase per mil-
lion (FPKM) values for each gene and treatment were
log transformed, and gene expression values were
centered and scaled to have mean zero and standard
deviation one across the row.
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Gene ontology enrichment analysis
Differentially expressed genes of interest were queried
for gene ontology (GO) term enrichment using DAVID
Bioinformatics Resources 6.8 [29, 30] with the back-
ground set to the entire C. elegans gene list. Each gene is
assigned one or more GO terms and categorized into
Biological Process, Molecular Function, and Cellular
Component. Gene sets of interest were analyzed using
the functional annotation chart and the “ALL” database
in DAVID for each GO category. Significant enrichment
of GO terms was determined using a Fisher’s exact test
[30]; this test associates a p-value, or EASE score, to
each GO term based on the number of genes associated
with that term as compared to background [30]. False-
discovery rate (FDR) correction of EASE scores, as im-
plemented by DAVID, was used to control for multiple
testing. GO terms were considered to be significantly
enriched if FDR adjusted p-value < 0.05.
Mutant generation using CRISPR/Cas9
CRISPR/Cas9 was used to generate mutations in
W02A2.8, F08G2.5, K08D8.4, and B0024.4. Guide RNA
(gRNA) sequences were chosen within the coding se-
quence of the gene of interest (GOI) using the CRISPR-
seek package in R to select guides with high efficacy, and
CRISPR design (https://crispr.mit.edu) to identify pos-
sible off-target effects. Two to four gRNAs were identi-
fied and constructed for each GOI (Additional File 10).
Double-stranded gRNA sequences consisted of 20 base
pairs prior to the PAM site (NGG) plus overhanging
base pairs on each end that overlapped with BsaI-cut
pRB1017 plasmid. This overlap allowed for proper
ligation of the gRNA sequence into BsaI-cut pRB1017
[56].
A co-CRISPR method, described in Arribere et al., was
used to facilitate detection of gene-editing events.
Briefly, an injection mix of 50 ng/μl Peft:Cas9 vector
[57], 20–25 ng/μl of dpy-10 gRNA [56], and 20–25 ng/μl
of each target gRNA-carrying plasmid were injected into
young adult worm gonads [58]. F1 Dpy worms were then
moved to new plates and allowed to lay eggs. DNA was
then isolated from F1 Dpy worms and amplified with
primers targeting genomic sites flanking the gRNAs of
the GOI (Additional File 10).
Gene-editing events were identified by differences in
amplicon size as compared to wild-type, indicating an
insertion or deletion in the gene. Worms containing
mutant alleles were then sequenced to determine the
molecular lesion and outcrossed twice to wild-type
males to eliminate possible off-target mutations. None
of the mutations we generated resulted in a visible
phenotypic effect. The deletion in W02A2.8 removes
the start codon of the gene, whereas mutations in
F08G2.5, K08D8.4, and B0024.4 result in a frameshift
of the coding sequence. These molecular lesions sug-
gest loss-of-function mutations. A summary of
CRISPR/Cas9 generated alleles is shown in Additional
File 4.
Generation of expression construct strains
NEBuilder HiFi DNA Assembly (New England BioLabs)
was used to assemble the vector backbone (pPD95.75),
promoter and gene of interest (GOI), and fluorescent tag
(wrmScarlet). DNA vectors are assembled by ligating
fragments with overlapping sequence using an endo-
nuclease to create single-stranded overhangs within the
overlap sequences and ligase to ligate the fragments to-
gether. In this case, the three fragments were generated
via PCR using high fidelity Phusion DNA Polymerase
(Thermo Fisher Scientific). Fragment 1, encoding the
fluorescent protein wrmScarlet, was amplified from
pSEM89_egl-23::SL2::wrmScarlet [59] using forward pri-
mer 5′- ATGGTCAGCAAGGGAGAGGCAG − 3′ and
reverse primer 5′- TTACTTGTAGAGCTCGTCCATT
CCTCC − 3′. Fragment 2, the plasmid pPD95.75, which
contains GFP followed by the unc-54 3’UTR, was ampli-
fied using forward primer 5′- GACGAGCTCTACAA
GTAACATTCGTAGAATTCCAACTGAGCG − 3′ and
reverse primer 5′- TTTTTCTACCGGTACCCT
CCAAGGG − 3′. This generated a linearized vector
backbone that included a majority of the plasmid, ex-
cluding the GFP coding sequence. Fragment 3, which
contains the GOI driven by its endogenous promoter
(either 2 kb upstream of the gene or to the nearest up-
stream gene) and differed for each gene, was amplified
with the following primers: F19B2.5 driven by the
F19B2.5 promoter (pF19B2.5::F19B2.5) forward primer
5′- GGAGGGTACCGGTAGAAAAATGATTATTTC
CGGCTCGGG - 3′ and reverse primer 5′- CTCCCT
TGCTGACCATCTGGCTGTCGTCGGCTC - 3′, and
K08D8.4 driven by the K08D8.4 promoter (pK08D8.4::
K08D8.4) forward primer 5′- GAGGGTACCGGTA-
GAAAAACACCCAAGGATTTGAAG − 3′ and reverse
primer 5′- CTCTCCCTTGCTGACCATGACCAGCA
TAACAAAACC − 3′. The primers used to amplify the
vector backbone and the promoter/GOI fragment con-
tain the appropriate overlap sequence, resulting in circu-
lar assembly of the promoter and GOI fragment ligated
to the wrmScarlet fragment ligated to the vector back-
bone. Fragments were then gel purified using PureLink™
Quick Gel Extraction Kit (Invitrogen), followed by as-
sembly and cloning using NEBuilder HiFi Assembly
Master Mix and Cloning Kit following manufacturer’s
protocol.
Colonies containing possible positive constructs after
cloning were tested by PCR to ensure the fragments
were assembled correctly. DNA was extracted from con-
firmed correct colonies. Finally, 20–50 ng/ul of each
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construct along with 20 ng/ul dpy-10(+) plasmid were
injected into Dpy worms. F2 wild-type worms were then
screened for wrmScarlet expression, and 3 independent
transgene-containing lines were obtained for each GOI,
with one representative line chosen for further analysis.
Gene expression analysis
Nematodes containing extrachromosomal or integrated
alleles for transcriptional or translational fluorescent
protein fusions were moved to treatment bacteria
(OP50, K279a, JCMS, or JV3) at the L4 stage. After 12
and 24 h of exposure to treatment bacteria, nematodes
were anesthetized (10 mM sodium azide) for observation
at 100x magnification using a Leica DM6 microscope
equipped with epifluorescence and differential interfer-
ence contrast (DIC) optics. To quantify expression, 10–
18 nematodes expressing each construct were imaged
per treatment. We quantified expression within the in-
testine, the main immune organ of the worm, by mark-
ing the region posterior of the pharynx to the posterior
intestine as a region of interest (ROI) and quantifying
average fluorescent intensity (pixel sum within region /
area) using LAX software (Leica). Mean average intensities
were compared across treatments at each time point (12
and 24 h) using a Tukey HSD multiple comparison test in
R. Images were also taken of young adult worms contain-
ing expression constructs exposed to OP50 at 400x mag-
nification to show localization of expression.
C. elegans survival assays
Treatment bacteria were cultured in liquid LB (with
Ampicillin for S. maltophilia strains) overnight and 75 μl
of bacteria were plated onto NGM agar plates the day
prior to use. Worms were bleached to synchronize and
reared at 20 °C on lawns of E. coli OP50. For survival as-
says, 10–12 L4 worms were transferred to each treat-
ment plate, with three replicates of each treatment, and
maintained at 25 °C. Worms were transferred to new
plates every day until they stopped laying eggs to separ-
ate them from their progeny. Surviving worms were re-
corded each day and dead worms were removed from
plates, as determined by lack of movement following
prodding with a platinum wire pick. Plates that became
contaminated or worms that crawled off the agar and
died were removed from data analysis.
Statistical analyses were performed in R to determine
differences between the independent variable nematode
genotype, with the dependent variable being the probabil-
ity of nematode death on a given day. Survival probability
estimates over time were determined using the Kaplan-
Meier formula using the survival package in R. The Cox
proportional hazards mixed effects model was then used
to compare the effects of nematode genotype using the
coxme package in R. Wild-type worms were included in
every round of experimentation, and during analysis, mu-
tant nematode strains were compared to wild-type nema-
todes from all experimental rounds. The experimental
rounds were treated as random variables and differences
between rounds were accounted for within the model.
General linear hypothesis tested was performed using
the multcomp package in R to compare mutant nema-
tode strains to wild-type nematodes on each bacterial
treatment. The Benjamini-Hochberg procedure was used
to adjust p-values for false discovery rates associated
with multiple comparisons, with adjusted p-values < 0.05
considered to be significant. The relative survival heat-
map was made in R with ggplot2 using the –(β) value
for each comparison to wild-type.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12866-020-01771-1.
Additional file 1 Differentially expressed genes between treatment
comparisons. List of all differentially expressed genes between
comparisons. Genes were considered differentially expressed if fold-
change > 2 and FDR-adjusted p-value < 0.05. Fragments per kilobase per
million (FPKM) values are shown for each treatment. Additional sheets
contain CPSR, VSR, and JSR genes with FPKM values and up/down-regula-
tion in reference to the pathogenic strains (up/down-regulated in re-
sponse to JV3 and/or JCMS). Asterisk indicates different direction of
regulation depending on the comparison considered.
Additional file 2. GO analysis of upregulated CPSR and downregulated
VSR genes. Gene ontology (GO) enrichment analysis was performed on
the upregulated CPSR genes or the downregulated VSR genes using
DAVID Bioinformatics Resources 6.8. GO analysis identifies terms relating
to the biological process, molecular function, or cellular component that
are significantly enriched among a list of genes. Indented terms indicate
child terms, or subcategories, of the term listed above, with the parent
term left-aligned. Note that the degree of indention of each term does
not reflect absolute GO term level within each category. Count is the
number of genes corresponding to each GO term. Percent is the count /
total considered in analysis. FDR is the false discovery rate-corrected EASE
enrichment score to account for multiple testing. Only terms with FDR <
0.05 and the most descriptive term for each unique gene list are shown.
Additional file 3. CPSR and VSR genes ordered based on gene network
rank. WormNet v2 was queried with the 145 CPSR genes or 225 VSR
genes. Connected genes are ordered based on WormNet score, which is
based on the number of connections that gene has and the strength of
the evidence for those connections (Score). C = number of connected
CPSR genes to the listed gene. Up/down-regulated = direction of
differential expression in response to pathogenic compared to
nonpathogenic strains. Asterisk indicates different direction of regulation
depending on the comparison considered.
Additional file 4 CRISPR/Cas9 generated alleles. Genes for which
CRISPR/Cas9 alleles were generated are shown. Exons are indicated by
green boxes and introns are indicated by black lines. Gene sizes are not
to scale, but exon/intron size within genes is to scale. Relative location of
the gRNAs is indicated by circles above the gene, and location of
mutation is indicated in red (lines for deletions, triangles for insertions).
All isoforms of K08D8.4 and W02A2.8 are shown. K08D8.4 mutations are
predicted to result in loss of function of all isoforms; W02A2.8c may be
expressed but is not differentially expressed between treatments.
Mutation sequence and flanking sequence is shown on the right, with
mutation sequence shown in red font (number in parentheses represents
size of deletion).
Additional file 5 Mutations in CPSR genes result in a variety of survival
patterns upon S. maltophilia exposure. Survivorship of wild-type
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nematodes and CPSR mutants on S. maltophilia JCMS, K279a, JV3, and E.
coli OP50. Survival estimates were determined using Kaplan-Meier esti-
mates generated in R. For these experiments, 10–12 worms were syn-
chronized, picked onto each treatment bacterial lawn (3 plates per
treatment/nematode combination) and the number of living worms was
recorded daily. 2–3 replicates were completed for all bacterial and C. ele-
gans strain combinations. Sample sizes, hazard ratios and p-values gener-
ated form Cox proportional hazards tests are shown in Table 3.
Additional file 6 Mutations in VSR genes result in a variety of survival
patterns upon S. maltophilia exposure. Survivorship of wild-type
nematodes and VSR mutants on S. maltophilia JCMS, K279a, JV3, and E.
coli OP50. Survival estimates were determined using Kaplan-Meier esti-
mates generated in R. For these experiments, 10–12 worms were syn-
chronized, picked onto each treatment bacterial lawn (3 plates per
treatment/nematode combination) and the number of living worms was
recorded daily. 2–3 replicates were completed for all bacterial and C. ele-
gans strain combinations. Sample sizes, hazard ratios and p-values gener-
ated form Cox proportional hazards tests are shown in Table 3.
Additional file 7 Mutations in JSR genes result in a variety of survival
patterns upon S. maltophilia exposure. Survivorship of wild-type
nematodes and JSR mutants on S. maltophilia JCMS, K279a, JV3, and E.
coli OP50. Survival estimates were determined using Kaplan-Meier esti-
mates generated in R. For these experiments, 10–12 worms were syn-
chronized, picked onto each treatment bacterial lawn (3 plates per
treatment/nematode combination) and the number of living worms was
recorded daily. 2–3 replicates were completed for all bacterial and C. ele-
gans strain combinations. Sample sizes, hazard ratios and p-values gener-
ated form Cox proportional hazards tests are shown in Table 3.
Additional file 8 Expression construct quantification at 12 and 24 h.
Expression levels of several CPSR (T24B8.5, F19B2.5, K08D8.4) and VSR
(sodh-1, acdh-1, dhs-3) genes using transcriptional or translational
fluorescent protein fusions upon exposure to S. maltophilia or E. coli
OP50. L4 worms containing expression constructs were moved to S.
maltophilia K279a, JCMS, JV3, or E. coli OP50. After 12 and 24 h, images
were taken of 10–18 worms for each treatment and expression construct,
and average intensity was measured for each worm. Plots show mean
average intensity and standard error for each time, treatment, and
expression construct. Letters indicate significant differences across
treatments for each time point (Tukey’s HSD).
Additional file 9 Expression construct localization. Expression of several
CPSR (T24B8.5, F19B2.5, K08D8.4) and VSR (sodh-1, acdh-1, dhs-3) genes
using transcriptional or translational fluorescent protein fusions upon
exposure to E. coli OP50 at 400x in young adult worms. T24B8.5, F19B2.5
and dhs-3 are only expressed in the intestine, so the anterior intestine is
shown. K08D8.4, acdh-1 and sodh-1 are also expressed in the head, which
is shown. Brackets indicate head and intestine region on each worm.
Unclosed brackets signify that region extends out of frame. Scale bar
indicates 20 μm, anterior is to the left, and ventral is up for all pictures.
Note that expression in the AIY interneuron (arrow) in the T24B8.5
transgenic strain is due to a ttx-3:GFP marker and not T24B8.5 expression
and the sodh-1 expression construct contains a nuclear localization signal.
Additional file 10 CRISPR/Cas9 target gene primers. Forward and
reverse primers for each gRNA were annealed and ligated into pRB1017.
gRNA sequence (20 bp prior to the PAM site) are underlined for each
primer, non-underlined bases are included in the primer sequence for
proper ligation into BsaI digested pRB1017. Primers flanking the gRNA tar-
get loci were used to amplify DNA from candidate mutant worms to de-
tect insertions or deletions based on amplicon size. Odd numbers of
flanking primers listed for any gene were tested in combinations (forward
primer was tested with each reverse primers).
Abbreviations
FDR: False discovery rate; CPSR: Common pathogenic S. maltophilia response;
JSR: JCMS-specific response; VSR: JV3-specific response; GO: Gene ontology;
DAVID: Database for Annotation, Visualization, and Integrated Discovery;
AUC: Area under curve; ROC: Receiver operating characteristic;
FPKM: Fragment per kilobase per million; CRISPR: Clustered regularly
interspersed short palindromic repeats
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